Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in Incidence and Risk Factors of HIV-Associated Disseminated Histoplasmosis in the Americas: An Observational Cohort Study.

Journal of the International AIDS Society·2026
Same author

Generating synthetic multi-national longitudinal cohorts for clinically grounded HIV research.

Nature communications·2026
Same author

Use of Integrase Strand Transfer Inhibitors Among Children Living With HIV in Latin America and the Caribbean.

The Pediatric infectious disease journal·2026
Same author

Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium.

International journal of cancer·2026
Same author

Incidence and outcomes of childhood status epilepticus in Kano, northern Nigeria.

Epilepsia open·2026
Same author

Safety and tolerability of the ACE-inhibitor lisinopril among Nigerian adults with HIV: preliminary pilot data from a randomized clinical trial.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Related Experiment Video

Updated: Jun 26, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Bryan E Shepherd1, Peter B Gilbert, Thomas Lumley

  • 1Department of Biostatistics, Vanderbilt University, Nashville, TN 37232 (E-mail: bryan.shepherd@vanderbilt.edu ).

Journal of the American Statistical Association
|January 6, 2009
PubMed
Summary
This summary is machine-generated.

This study introduces new methods for analyzing outcomes in human immunodeficiency virus (HIV) vaccine trials, focusing on the survival causal effect in infected participants. These methods help understand treatment effects on post-infection events.

Keywords:
Acquired immune deficiency syndromeCausal inferenceKaplan–MeierPrincipal stratification

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: Jun 26, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Trials

Background:

  • Randomized studies often assess treatment effects on outcomes within specific subgroups.
  • Preventative human immunodeficiency virus (HIV) vaccine trials require analysis of post-infection outcomes, which may be right-censored.

Purpose of the Study:

  • To present sensitivity analysis methods for causal comparisons of post-infection outcomes in HIV vaccine trials.
  • To estimate the survival causal effect, focusing on the 'always-infected' principal stratum.

Main Methods:

  • Developed nonparametric, semiparametric, and parametric methods for causal effect estimation.
  • Focused on the difference in probabilities of not experiencing an event between vaccine and placebo arms, conditional on infection.
  • Assumed monotonicity: infected subjects in the vaccine arm would have been infected in the placebo arm.

Main Results:

  • Proposed novel statistical methods for analyzing causal effects in a key subgroup of HIV vaccine trials.
  • Applied these methods to data from VaxGen's AIDSVAX B/B Phase III preventative HIV vaccine trial.

Conclusions:

  • The developed methods provide a framework for causal inference on post-infection outcomes in HIV vaccine trials.
  • Sensitivity analysis is crucial for understanding treatment effects in the presence of post-randomization events.